Literature DB >> 27397544

Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia/reperfusion renal injury in rats.

Yu Fu1, Qing Lin1, Tao Gong1, Xun Sun1, Zhi-Rong Zhang1.   

Abstract

AIM: We previously reported a novel triptolide (TP)-glucosamine conjugate (TPG) that specifically accumulated in kidneys and protected renal function from acute ischemia/reperfusion (I/R) injury in rats. In this study we further examined the molecular mechanisms underlying the renoprotective action of TPG.
METHODS: The renal-targeting of TPG was investigated in a human proximal renal tubular epithelial cell line (HK-2) by measuring cell uptake of TP or TPG. The effects of TP or TPG on cell cycle distribution and apoptosis rate of HK-2 cells were assessed, and the activities of caspase-3 and caspase-9 were also measured. SD rats were subjected to bilateral renal ischemia by temporarily clamping both renal pedicles. The rats were administered TP (4.17 μmol·kg-1·d-1, iv) or TPG (4.17 μmol·kg-1·d-1, iv) for 3 d before the renal surgery. The kidneys were harvested after 24 h of recovery from the surgery. The levels of oxidative stress, proinflammatory cytokines, chemotactic cytokines and intracellular adhesion molecules in kidneys were examined.
RESULTS: The uptake of TPG in HK-2 cells was 2-3 times higher than that of TP at the concentrations tested. Furthermore, TPG targeting the proximal tubules was mediated through interactions with megalin receptors. TP (40-160 nmol/L) concentration-dependently increased G2/M arrest, apoptosis and caspase-3/caspase-9 activity in HK-2 cells, whereas the same concentrations of TPG did not show those features when compared with the control group. In I/R-treated rats, TPG administration caused more robust down-regulation of proinflammatory cytokines (TNF-α, IL-6, IL-1, TGF-β) and chemotactic cytokines (MCP-1) in the kidneys compared with TP administration, suggesting the inhibition of the proliferation and accumulation of lymphocytes. And TPG administration also caused more prominent inhibition on the levels of oxidative stress and intracellular adhesion molecules in the kidneys, compared with TP administration.
CONCLUSION: The renal-targeting TPG is more effective and less toxic than TP, in amelioration of I/R-induced rat renal injury, which may provide a new avenue for the treatment of acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27397544      PMCID: PMC5099408          DOI: 10.1038/aps.2016.44

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  42 in total

Review 1.  Reactive oxygen species and acute renal failure.

Authors:  K A Nath; S M Norby
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

Review 2.  Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells.

Authors:  M E M Dolman; S Harmsen; G Storm; W E Hennink; R J Kok
Journal:  Adv Drug Deliv Rev       Date:  2010-08-16       Impact factor: 15.470

3.  Oxidative and nitrosative stress in acute renal ischemia.

Authors:  E Noiri; A Nakao; K Uchida; H Tsukahara; M Ohno; T Fujita; S Brodsky; M S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

4.  Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat.

Authors:  J M Forbes; T D Hewitson; G J Becker; C L Jones
Journal:  Kidney Int       Date:  2000-06       Impact factor: 10.612

5.  Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB.

Authors:  Fion L Sung; Tong Y Zhu; Kathy K W Au-Yeung; Yaw L Siow; Karmin O
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 6.  Triptolide: progress on research in pharmacodynamics and toxicology.

Authors:  Xiao-Jiaoyang Li; Zhen-Zhou Jiang; Lu-yong Zhang
Journal:  J Ethnopharmacol       Date:  2014-06-13       Impact factor: 4.360

7.  Albumin fusion prolongs the antioxidant and anti-inflammatory activities of thioredoxin in mice with acetaminophen-induced hepatitis.

Authors:  Ryota Tanaka; Yu Ishima; Hitoshi Maeda; Azusa Kodama; Saori Nagao; Hiroshi Watanabe; Victor Tuan Giam Chuang; Masaki Otagiri; Toru Maruyama
Journal:  Mol Pharm       Date:  2014-03-10       Impact factor: 4.939

Review 8.  Regulation and pathological role of p53 in cisplatin nephrotoxicity.

Authors:  Man Jiang; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

9.  Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.

Authors:  Jun Ma; Moul Dey; Hui Yang; Alexander Poulev; Reneta Pouleva; Ruth Dorn; Peter E Lipsky; Edward J Kennelly; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-03-30       Impact factor: 4.072

Review 10.  Kidney-targeted drug delivery systems.

Authors:  Peng Zhou; Xun Sun; Zhirong Zhang
Journal:  Acta Pharm Sin B       Date:  2014-01-23       Impact factor: 11.413

View more
  5 in total

1.  Improved creatinine-based early detection of acute kidney injury after cardiac surgery.

Authors:  Ferdinand Vogt; Janez Zibert; Alenka Bahovec; Francesco Pollari; Joachim Sirch; Matthias Fittkau; Thomas Bertsch; Martin Czerny; Giuseppe Santarpino; Theodor Fischlein; Jurij M Kalisnik
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28

Review 2.  A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.

Authors:  Shao-Ru Chen; Yan Dai; Jing Zhao; Ligen Lin; Yitao Wang; Ying Wang
Journal:  Front Pharmacol       Date:  2018-02-14       Impact factor: 5.810

3.  Targeted therapy of rheumatoid arthritis via macrophage repolarization.

Authors:  Xu Zhou; Dandan Huang; Runkong Wang; Mingquan Wu; Liyang Zhu; Wei Peng; He Tu; Xuangeng Deng; He Zhu; Zhong Zhang; Xinming Wang; Xi Cao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 4.  The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation.

Authors:  Danping Fan; Qingqing Guo; Jiawen Shen; Kang Zheng; Cheng Lu; Ge Zhang; Aiping Lu; Xiaojuan He
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

Review 5.  Bioresponsive drug delivery systems for the treatment of inflammatory diseases.

Authors:  Yin Dou; Chenwen Li; Lanlan Li; Jiawei Guo; Jianxiang Zhang
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.